Amarin CEO on Vascepa heart drug trial

2:42 PM ET Mon, 24 Sept 2018

John Thero, Amarin president and CEO, discusses Amarin's successful clinical trial for its fish oil-derived heart drug, Vascepa. CNBC's Meg Tirrell also weighs in.